Literature DB >> 28501958

Heightened perception of breast cancer risk in young women at risk of familial breast cancer.

Rachael Glassey1, Moira O'Connor2, Angela Ives3, Christobel Saunders4, Sarah O'Sullivan5, Sarah J Hardcastle2.   

Abstract

The objective of this study was to explore the factors that influence perceived personal risk of developing breast cancer (BC) in younger women (<35) who are considering or have undergone bilateral prophylactic mastectomy (BPM). Qualitative interviews guided by interpretative phenomenological analysis were conducted with 46 women who had a strong family history of BC and had either undergone (n = 26) or were considering (n = 20) BPM. Participants were recruited from Australia and New Zealand via hospitals, a genetics clinic, a research cohort, a registry and online. Three main themes were identified: information that increases fear of BC and death, underlying anxiety and fear and screening anxiety. A further two themes: relief following surgery and confusion about residual risk following surgery were identified. Younger women (<35) appeared to have heightened and sometimes inaccurate perceptions of their BC risk. They appeared less relieved of anxiety and fear of developing BC by BPM surgery, in comparison to previous research with older women (>40). Those who had undergone BPM seemed more anxious about their risk of developing BC than those who were still considering surgery. This research has important implications for practice, particularly improving communication of accurate risk statistics. Future research should examine why some women interpret information differently and explore the benefits of psychological consultation for very anxious women.

Entities:  

Keywords:  Familial cancer; Prophylactic mastectomy; Risk perception; Young women

Mesh:

Substances:

Year:  2018        PMID: 28501958     DOI: 10.1007/s10689-017-0001-2

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  30 in total

1.  Psychological factors associated with the intention to choose for risk-reducing mastectomy in family cancer clinic attendees.

Authors:  C M G van Driel; J C Oosterwijk; E J Meijers-Heijboer; C J van Asperen; I A Zeijlmans van Emmichoven; J de Vries; M J E Mourits; L Henneman; D R M Timmermans; G H de Bock
Journal:  Breast       Date:  2016-09-14       Impact factor: 4.380

2.  The psychosocial impact of bilateral prophylactic mastectomy: prospective study using questionnaires and semistructured interviews.

Authors:  M B Hatcher; L Fallowfield; R A'Hern
Journal:  BMJ       Date:  2001-01-13

Review 3.  Decision making, psychological wellbeing and psychosocial outcomes for high risk women who choose to undergo bilateral prophylactic mastectomy - A review of the literature.

Authors:  Rachael Glassey; Angela Ives; Christobel Saunders; Toni Musiello
Journal:  Breast       Date:  2016-06-15       Impact factor: 4.380

Review 4.  Risk reduction and survival benefit of prophylactic surgery in BRCA mutation carriers, a systematic review.

Authors:  Kandice K Ludwig; Joan Neuner; Annabelle Butler; Jennifer L Geurts; Amanda L Kong
Journal:  Am J Surg       Date:  2016-07-18       Impact factor: 2.565

5.  Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.

Authors:  Nasim Mavaddat; Susan Peock; Debra Frost; Steve Ellis; Radka Platte; Elena Fineberg; D Gareth Evans; Louise Izatt; Rosalind A Eeles; Julian Adlard; Rosemarie Davidson; Diana Eccles; Trevor Cole; Jackie Cook; Carole Brewer; Marc Tischkowitz; Fiona Douglas; Shirley Hodgson; Lisa Walker; Mary E Porteous; Patrick J Morrison; Lucy E Side; M John Kennedy; Catherine Houghton; Alan Donaldson; Mark T Rogers; Huw Dorkins; Zosia Miedzybrodzka; Helen Gregory; Jacqueline Eason; Julian Barwell; Emma McCann; Alex Murray; Antonis C Antoniou; Douglas F Easton
Journal:  J Natl Cancer Inst       Date:  2013-04-29       Impact factor: 13.506

6.  Understanding the experience of prophylactic bilateral mastectomy: a qualitative study of ten women.

Authors:  S M Lloyd; M Watson; G Oaker; N Sacks; U Querci della Rovere; G Gui
Journal:  Psychooncology       Date:  2000 Nov-Dec       Impact factor: 3.894

7.  Preventing breast and ovarian cancers in high-risk BRCA1 and BRCA2 mutation carriers.

Authors:  Ian M Collins; Roger L Milne; Prue C Weideman; Sue-Anne McLachlan; Michael L Friedlander; John L Hopper; Kelly-Anne Phillips
Journal:  Med J Aust       Date:  2013-11-18       Impact factor: 7.738

8.  Psychological reactions, quality of life, and body image after bilateral prophylactic mastectomy in women at high risk for breast cancer: a prospective 1-year follow-up study.

Authors:  Yvonne Brandberg; Kerstin Sandelin; Staffan Erikson; Göran Jurell; Annelie Liljegren; Annika Lindblom; Ann Lindén; Anna von Wachenfeldt; Marie Wickman; Brita Arver
Journal:  J Clin Oncol       Date:  2008-08-20       Impact factor: 44.544

9.  Intentions for risk-reducing surgery among high-risk women referred for BRCA1/BRCA2 genetic counseling.

Authors:  Angie Tong; Scott Kelly; Rachel Nusbaum; Kristi Graves; Beth N Peshkin; Heiddis B Valdimarsdottir; Marie Wood; Wendy McKinnon; Judy Garber; Shelley R McCormick; Lina Jandorf; Marc D Schwartz
Journal:  Psychooncology       Date:  2014-05-17       Impact factor: 3.894

Review 10.  How do women at increased breast cancer risk perceive and decide between risks of cancer and risk-reducing treatments? A synthesis of qualitative research.

Authors:  Hannah G Fielden; Stephen L Brown; Pooja Saini; Helen Beesley; Peter Salmon
Journal:  Psychooncology       Date:  2017-01-26       Impact factor: 3.894

View more
  8 in total

1.  Anxiety and depression among racial/ethnic minorities and impoverished women testing positive for BRCA1/2 mutations in the United States.

Authors:  Kate E Dibble; Avonne E Connor
Journal:  Support Care Cancer       Date:  2022-03-26       Impact factor: 3.359

2.  Influences on Satisfaction with Reconstructed Breasts and Intimacy in Younger Women Following Bilateral Prophylactic Mastectomy: a Qualitative Analysis.

Authors:  Rachael Glassey; Moira O'Connor; Angela Ives; Christobel Saunders; Sarah J Hardcastle
Journal:  Int J Behav Med       Date:  2018-08

3.  "I wish that there was more info": characterizing the uncertainty experienced by carriers of pathogenic ATM and/or CHEK2 variants.

Authors:  Kathryn G Reyes; Cheyla Clark; Meredith Gerhart; Ainsley J Newson; Kelly E Ormond
Journal:  Fam Cancer       Date:  2021-04-15       Impact factor: 2.375

4.  Development of a Web-based Family Intervention for BRCA Carriers and Their Biological Relatives: Acceptability, Feasibility, and Usability Study.

Authors:  Maria C Katapodi; Miyeon Jung; Ann M Schafenacker; Kara J Milliron; Kari E Mendelsohn-Victor; Sofia D Merajver; Laurel L Northouse
Journal:  JMIR Cancer       Date:  2018-04-13

5.  Breast MRI texture analysis for prediction of BRCA-associated genetic risk.

Authors:  Georgia Vasileiou; Maria J Costa; Christopher Long; Iris R Wetzler; Juliane Hoyer; Cornelia Kraus; Bernt Popp; Julius Emons; Marius Wunderle; Evelyn Wenkel; Michael Uder; Matthias W Beckmann; Sebastian M Jud; Peter A Fasching; Alexander Cavallaro; André Reis; Matthias Hammon
Journal:  BMC Med Imaging       Date:  2020-07-29       Impact factor: 1.930

6.  Psychological Distress and Coping Ability of Women at High Risk of Hereditary Breast and Ovarian Cancer before Undergoing Genetic Counseling-An Exploratory Study from Germany.

Authors:  Beate Vajen; Magdalena Rosset; Hannah Wallaschek; Eva Baumann; Brigitte Schlegelberger
Journal:  Int J Environ Res Public Health       Date:  2021-04-19       Impact factor: 3.390

7.  Residential Locale Is Associated with Disparities in Genetic Testing-Related Outcomes Among BRCA1/2-Positive Women.

Authors:  Kate E Dibble; Avonne E Connor
Journal:  J Racial Ethn Health Disparities       Date:  2022-02-17

8.  Predictors and interdependence of family support in a random sample of long-term young breast cancer survivors and their biological relatives.

Authors:  Maria C Katapodi; Katrina R Ellis; Franziska Schmidt; Christos Nikolaidis; Laurel L Northouse
Journal:  Cancer Med       Date:  2018-09-05       Impact factor: 4.452

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.